SET
0337
CBHB
0339
COLFORM
0341
4
TECHSTORE
0343
5
NORTHERN
0340
(FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.10%71.74M | -10.26%16.52M | -4.36%18.17M | 17.32%19.45M | -0.48%17.6M | 18.46%71.67M | 19.69%18.4M | 33.83%19M | 1.12%16.58M | 21.70%17.69M |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -0.86%64.12M | -11.26%14.78M | -2.23%16.71M | 12.64%17.06M | -1.36%15.57M | 731.39%64.67M | 148.20%16.65M | 23.75%17.1M | 0.31%15.15M | 17.73%15.78M |
Other operating expenses | -1.19%65.24M | -13.83%14.92M | -2.45%16.97M | 13.54%17.53M | -0.35%15.83M | 1,921.22%66.03M | 143.64%17.31M | 23.84%17.39M | 0.85%15.44M | 16.93%15.89M |
Total other operating income | -16.97%1.13M | -78.43%143K | -15.38%253K | 60.69%466K | 155.34%263K | 9.63%1.36M | 7.28%663K | 29.44%299K | 40.10%290K | -42.78%103K |
Operating profit | 8.95%7.62M | -0.80%1.74M | -23.50%1.46M | 66.81%2.39M | 6.83%2.03M | 104.66%7M | 186.47%1.75M | 396.35%1.91M | 10.56%1.43M | 69.07%1.9M |
Net non-operating interest income (expenses) | 23.53%-52K | 23.53%-13K | 29.41%-12K | 17.65%-14K | 23.53%-13K | -4.82%-68K | 9.93%-17K | -13.33%-17K | -21.43%-17K | 0.00%-17K |
Non-operating interest expense | -23.53%52K | -23.53%13K | -29.41%12K | -17.65%14K | -23.53%13K | 4.82%68K | -9.93%17K | 13.33%17K | 21.43%17K | 0.00%17K |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -34.32%111K | 105.26%1K | -75.44%14K | 108.16%102K | -107.32%-6K | 200.82%169K | -138.63%-19K | 181.43%57K | -23.44%49K | 530.77%82K |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 8.23%7.68M | 0.58%1.73M | -24.97%1.46M | 69.17%2.48M | 2.34%2.01M | 108.15%7.1M | 167.36%1.72M | 550.84%1.95M | 8.83%1.47M | 75.47%1.97M |
Income tax | 53.22%2.26M | 783.56%499K | -35.93%337K | 97.41%914K | -8.56%513K | 11.91%1.48M | -113.14%-73K | 292.54%526K | 15.75%463K | 143.91%561K |
Net income | -3.59%5.42M | -31.38%1.23M | -20.92%1.12M | 56.13%1.57M | 6.69%1.5M | 168.92%5.62M | 1,963.08%1.79M | 760.61%1.42M | 5.91%1M | 57.80%1.41M |
Net income continuous operations | -3.59%5.42M | -31.38%1.23M | -20.92%1.12M | 56.13%1.57M | 6.69%1.5M | 168.92%5.62M | 1,963.08%1.79M | 760.61%1.42M | 5.91%1M | 57.80%1.41M |
Noncontrolling interests | -13K | -4K | -2K | -1K | -6K | 0 | 0 | 0 | 0 | 0 |
Net income attributable to the company | -3.36%5.43M | -31.16%1.23M | -20.77%1.13M | 56.23%1.57M | 7.11%1.51M | 168.92%5.62M | 1,963.08%1.79M | 760.61%1.42M | 5.91%1M | 57.80%1.41M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -3.36%5.43M | -31.16%1.23M | -20.77%1.13M | 56.23%1.57M | 7.11%1.51M | 168.92%5.62M | 1,963.08%1.79M | 760.61%1.42M | 5.91%1M | 57.80%1.41M |
Gross dividend payment | ||||||||||
Basic earnings per share | -3.72%0.0569 | -31.38%0.0129 | -20.27%0.0118 | 56.19%0.0164 | 7.48%0.0158 | 174.88%0.0591 | 1,780.00%0.0188 | 770.59%0.0148 | 8.25%0.0105 | 61.54%0.0147 |
Diluted earnings per share | 0.00%0.0569 | -28.73%0.0129 | -16.31%0.0118 | 69.07%0.0164 | 20.61%0.0158 | 170.95%0.0569 | 3,520.00%0.0181 | 729.41%0.0141 | 2.11%0.0097 | 50.57%0.0131 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.